Verso Biosense Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.5M
- Investors
-
5
Verso Biosense General Information
Description
Developer of an intra-uterine sensor technology designed to optimize fertility treatment and uterine health of patients. The company's technology helps to measure dissolved oxygen (DO), pH, and temperature in the uterus of women seeking medical help to improve their fertility, the device transmits data to the proprietary software to measure key uterine parameters, enabling healthcare professionals to improve the diagnosis of uterine dysfunction and reproductive outcomes.
Contact Information
Website
www.versobiosense.comCorporate Office
- 115B Innovation Drive
- Milton Park
- Abingdon OX14 4RZ
- England, United Kingdom
Corporate Office
- 115B Innovation Drive
- Milton Park
- Abingdon OX14 4RZ
- England, United Kingdom
Verso Biosense Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 02-Jun-2023 | $4.5M | Completed | Clinical Trials - General | ||
| 6. Secondary Transaction - Private | 01-Aug-2022 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC | 03-Aug-2020 | Completed | Clinical Trials - General | |||
| 4. Grant | 01-Feb-2019 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series A) | 17-Jan-2019 | Completed | Clinical Trials - General | |||
| 2. Accelerator/Incubator | 18-Mar-2016 | Completed | Clinical Trials - General | |||
| 1. University Spin-Out | 01-Jan-2009 | Completed | Clinical Trials - General |
Verso Biosense Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 36,061 | $0.623832 | $23.74 | $23.74 | 1x | $23.74 | 4.5% | |
| Ordinary | 78,704 | $0.623832 | $11.89 | $11.89 | 1x | $11.89 | 9.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Verso Biosense Comparisons
Industry
Financing
Details
Verso Biosense Competitors (2)
One of Verso Biosense’s 2 competitors is Nemo Healthcare, a Formerly VC-backed company based in Veldhoven, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nemo Healthcare | Formerly VC-backed | Veldhoven, Netherlands | ||||
| Prima-Temp | Venture Capital-Backed | Boulder, CO |
Verso Biosense Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Verso Biosense Patents
Verso Biosense Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023332394-A1 | Intra-uterine monitoring and contraceptive system | Pending | 31-Aug-2022 | ||
| EP-4580564-A1 | Intra-uterine monitoring and contraceptive system | Active | 31-Aug-2022 | ||
| EP-4580564-B1 | Intra-uterine monitoring and contraceptive system | Active | 31-Aug-2022 | ||
| EP-4580564-C0 | Intra-uterine monitoring and contraceptive system | Active | 31-Aug-2022 | ||
| ES-3073226-T3 | Intra-uterine monitoring and contraceptive system | Active | 31-Aug-2022 | A61F6/14 |
Verso Biosense Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Verso Biosense Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dickson Family Office | Family Office | Minority | ||
| Government of UK | Government | Minority | ||
| Innovate UK | Government | |||
| Future Worlds | Accelerator/Incubator | |||
| University of Southampton | University |
Verso Biosense FAQs
-
When was Verso Biosense founded?
Verso Biosense was founded in 2009.
-
Where is Verso Biosense headquartered?
Verso Biosense is headquartered in Abingdon, United Kingdom.
-
What is the size of Verso Biosense?
Verso Biosense has 20 total employees.
-
What industry is Verso Biosense in?
Verso Biosense’s primary industry is Monitoring Equipment.
-
Is Verso Biosense a private or public company?
Verso Biosense is a Private company.
-
What is the current valuation of Verso Biosense?
The current valuation of Verso Biosense is .
-
What is Verso Biosense’s current revenue?
The current revenue for Verso Biosense is .
-
How much funding has Verso Biosense raised over time?
Verso Biosense has raised $13.3M.
-
Who are Verso Biosense’s investors?
Dickson Family Office, Government of UK, Innovate UK, Future Worlds, and University of Southampton have invested in Verso Biosense.
-
Who are Verso Biosense’s competitors?
Nemo Healthcare and Prima-Temp are competitors of Verso Biosense.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
